Medical Injection Molding Market Size, Share, Trends & Forecast 2034

The global medical injection molding market size reached USD 25.3 Billion in 2025, Expected to Hit USD 35.8 Billion, CAGR of 3.83% during forecast 2026-2034.

IMARC Group, a leading global market research and management consulting firm, has published its latest market intelligence report on the medical injection molding market. The global medical injection molding market size reached USD 25.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 35.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.83% during 2026-2034, driven by rising demand for single-use medical devices, expanding healthcare infrastructure and spending, growing aging populations and chronic disease burdens, and continuous advances in micro-molding, multi-material molding and automation across the global medical device supply chain.

The market is experiencing strong growth momentum as device makers look for high-precision, repeatable and sterile production methods. Syringes, inhalers, surgical instruments, diagnostic cartridges, catheter components and implantable parts all rely on injection molding to meet tight tolerances at scale. Demand for miniaturized and complex devices used in minimally invasive surgery, diagnostics and wearables is pushing molders to adopt cleanroom production, tighter process validation and advanced tooling. At the same time, strict regulatory, quality and biocompatibility standards favor suppliers that can deliver standardized, traceable output batch after batch.

How AI is Reshaping the Future of the Medical Injection Molding Market

1. AI-Powered Process Monitoring and Predictive Maintenance: Machine learning platforms connected to molding presses analyze pressure, temperature, cycle time and mold wear data in real time. They flag drift before it produces out-of-tolerance parts and schedule maintenance before unplanned downtime hits. For Class II and Class III devices, where a single rejected lot can disrupt hospital supply, this reduces scrap, protects validated processes and improves delivery reliability.
2. Computer Vision for Automated Quality Inspection: AI-driven vision systems inspect molded components for short shots, flash, sink marks, contamination and dimensional deviations at speeds manual checks cannot match. Inline inspection of syringe barrels, pipette tips and diagnostic cartridges supports zero-defect expectations in regulated markets across North America, Europe and Asia Pacific. It also creates the digital traceability records that auditors expect.
3. Simulation-Led Design and Faster Tooling Development: AI-assisted mold flow simulation and generative design help engineers optimize gate locations, cooling channels and wall thickness before steel is cut. This shortens development cycles for micro-molded and multi-material components. It also lowers the cost of iteration for new drug delivery devices, wearables and minimally invasive surgical tools.

Grab a sample PDF of this report:https://www.imarcgroup.com/medical-injection-molding-market/requestsample

Medical Injection Molding Market Trends and Drivers:

The global medical injection molding market is witnessing steady expansion. Infection control priorities, healthcare capacity building and rapid innovation in device design are reshaping how medical components are manufactured. Single-use devices are the foundation of demand, because hospitals and clinics increasingly prefer disposable products to reduce cross-contamination and the burden of reprocessing. The global medical disposables market is valued at USD 470.53 Billion, and a large share of those products, including syringes, IV components, specimen containers and surgical accessories, are produced through injection molding. Hot runner systems are especially valued here because they cut cycle times and material waste in high-volume production.

Healthcare infrastructure investment and public spending are adding a second layer of demand. India’s projected public healthcare spending of 1.9% of GDP reflects the policy push toward wider access to care, and the country’s production linked incentive scheme for medical devices, with an outlay of about INR 3,420 Crore, is encouraging domestic manufacturing of devices and their components. In developed markets, regulatory frameworks such as the European Union Medical Device Regulation and the United States FDA quality system requirements raise the bar for documentation, validation and traceability. These rules favor molders with cleanroom capability, ISO 13485 certification and mature quality systems, and they are driving consolidation and capacity expansion among qualified suppliers.

Demographics and disease patterns are strengthening demand further. The United Nations projects that the global population aged 80 and above will reach about 265 Million, increasing the need for diagnostics, infusion therapy, orthopedic and cardiovascular devices. Diabetes, cardiovascular and respiratory conditions are boosting demand for insulin pens, inhalers, catheters and monitoring devices, which are all precision-molded. Technology is another driver: micro-molding, multi-material molding, automation and Industry 4.0 tools allow manufacturers to produce smaller, more complex parts with lower variability. Cleanroom molding, personalized medicine, telemedicine and innovative device formats are also expanding the range of applications.

Ask an analyst for customized report:https://www.imarcgroup.com/medical-injection-molding-market

Medical Injection Molding Industry Segmentation:

The report has segmented the market into the following categories:

Breakup By System:

1. Hot Runner
2. Cold Runner

Hot runner systems account for the largest system segment. They shorten cycle times, reduce material waste and support consistent quality in high-volume production of disposable medical components, which makes them the preferred choice for syringes, diagnostic consumables and other precision parts. Cold runner systems remain a lower-cost option for selected applications.

Breakup By Class:

1. Class I
2. Class II
3. Class III

Class I covers the lowest-risk products, such as examination gloves. Class II covers moderate-risk devices, such as infusion pumps. Class III covers the highest-risk devices, such as pacemakers and artificial joints, where molding precision, cleanliness and traceability matter most.

Breakup By Material:

1. Plastic
2. Metal

Plastic accounts for the largest material segment, supported by its biocompatibility, moldability and cost efficiency across disposable and reusable devices. Metal injection molding serves implants and dental and surgical instruments, though cost, weight, sterilization and biocompatibility considerations limit broader adoption.

Breakup By Region:

1. North America
2. Asia Pacific
3. Europe
4. Latin America
5. Middle East and Africa

Asia Pacific dominates the global medical injection molding market with the largest regional share. The region benefits from expanding healthcare infrastructure, a large manufacturing base and strong demand in China and India. Europe holds a significant share, supported by stringent quality standards and regulatory compliance. North America continues to grow on the back of an advanced healthcare system and a dense base of medical device manufacturers.

Competitive Landscape:

The report provides a comprehensive analysis of the competitive landscape in the medical injection molding market with detailed profiles of all major companies, including:

1. AMS Micromedical LLC
2. Arburg GmbH + Co KG
3. Bright Plastics
4. C&J Industries
5. Currier Plastics Inc.
6. ENGEL Austria GmbH
7. Harbec
8. HTI Plastics (Pce Inc.)
9. Molded Rubber & Plastic Corporation
10. Metro Mold & Design
11. Milacron (Hillenbrand Inc.)
12. Proto Labs Inc.

What Does The Full Report Cover?

If you are tracking the medical injection molding market for investment decisions, market entry planning, competitive benchmarking, or strategic advisory, IMARC Group’s report gives you everything in one place:

1. Complete market sizing with revenue outlook covering the full projection period
2. Quantified growth driver analysis across system, class, material and regional markets
3. Sub-segment breakdowns for hot runner, cold runner, Class I, Class II, Class III, plastic and metal with individual share data
4. Regional coverage across North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa
5. Competitive profiles of leading companies with strategic landscape assessment
6. Porter’s Five Forces, value chain analysis and pricing intelligence
7. Latest technology trends covering cleanroom molding, micro-molding, multi-material molding, metal injection molding and automation shaping market competition

Recent News and Developments in Medical Injection Molding Market

1. September 2025: Schivo agreed to purchase Mecaplast SA, a Swiss maker of precision injection-molded parts for medical and life sciences. The deal strengthens Schivo’s European manufacturing footprint and its ability to serve medical device customers that need precision components.
2. April 2025: C&J Industries expanded its Meadville, Pennsylvania facility by 25,000 sq. ft. The expansion includes a 12,000 sq. ft. Class 8 cleanroom, 15 additional presses for the cleanroom and 5 in the white room, adding more than 100,000 production hours of capacity.
3. February 2025: Arterex acquired Phoenix S.r.l., a European medical device developer and manufacturer. The acquisition broadens Arterex’s engineering and manufacturing reach in Europe.
4. November 2024: Sanner Group announced a 60,500 sq. ft. plant in Greensboro, North Carolina, for Gilero, with ISO Class 7 and Class 8 cleanrooms. Production was scheduled to begin in the second quarter of 2025, adding regional capacity for medical and pharmaceutical device components.
5. October 2024: Biomerics launched vertically integrated metal injection molding services and opened a Metal Injection Molding Center of Excellence, widening its offering for implants and surgical instruments.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

Key Questions This Report Answers

1. What is the current global medical injection molding market size and what is its projected value?
2. Which system segment holds the largest share in the global medical injection molding market?
3. What are the key drivers of global medical injection molding market growth?
4. Which region dominates the global medical injection molding market and why?
5. How are single-use device demand, cleanroom molding and micro-molding reshaping competitive strategies in the industry?
6. Who are the top companies in the global medical injection molding market and what are their competitive strategies?
7. What are the investment and market entry opportunities across plastic, metal, hot runner and high-risk Class III device segments?

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Media and Sales Contact

IMARC Group

Email: [email protected]

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104